ONMD vs. NOTV, INUV, PHUN, DLHC, BIYA, BTOC, QRHC, FLNT, TZUP, and PIXY
Should you be buying OneMedNet stock or one of its competitors? The main competitors of OneMedNet include Inotiv (NOTV), Inuvo (INUV), Phunware (PHUN), DLH (DLHC), Baiya International Group (BIYA), Armlogi (BTOC), Quest Resource (QRHC), Fluent (FLNT), Thumzup Media (TZUP), and ShiftPixy (PIXY). These companies are all part of the "business services" industry.
OneMedNet vs.
OneMedNet (NASDAQ:ONMD) and Inotiv (NASDAQ:NOTV) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.
Inotiv has a consensus price target of $5.92, suggesting a potential upside of 198.82%. Given Inotiv's stronger consensus rating and higher possible upside, analysts clearly believe Inotiv is more favorable than OneMedNet.
Inotiv received 19 more outperform votes than OneMedNet when rated by MarketBeat users.
OneMedNet has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Inotiv has a beta of 3.96, indicating that its stock price is 296% more volatile than the S&P 500.
Inotiv has a net margin of -25.40% compared to OneMedNet's net margin of -1,093.61%. OneMedNet's return on equity of 0.00% beat Inotiv's return on equity.
In the previous week, OneMedNet had 3 more articles in the media than Inotiv. MarketBeat recorded 5 mentions for OneMedNet and 2 mentions for Inotiv. Inotiv's average media sentiment score of 0.66 beat OneMedNet's score of 0.57 indicating that Inotiv is being referred to more favorably in the news media.
0.9% of OneMedNet shares are owned by institutional investors. Comparatively, 18.2% of Inotiv shares are owned by institutional investors. 44.7% of OneMedNet shares are owned by insiders. Comparatively, 7.8% of Inotiv shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
OneMedNet has higher earnings, but lower revenue than Inotiv. OneMedNet is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks.
Summary
Inotiv beats OneMedNet on 11 of the 17 factors compared between the two stocks.
Get OneMedNet News Delivered to You Automatically
Sign up to receive the latest news and ratings for ONMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OneMedNet Competitors List
Related Companies and Tools
This page (NASDAQ:ONMD) was last updated on 5/2/2025 by MarketBeat.com Staff
Buy ONMD Stock Free ONMD Stock Alerts